---
schema_version: "secwatch.filing_event.v1"
accession: "0001517022-24-000007"
form_type: "8-K"
ticker: "AKBA"
cik: "0001517022"
company_name: "Akebia Therapeutics, Inc."
filed_at: "2024-01-08T23:59:59+00:00"
generated_at: "2026-06-07T02:14:14.601760+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Akebia Therapeutics appoints Richard Malabre as Chief Accounting Officer

## Summary
- Richard C. Malabre named CAO effective January 8, 2024, reporting to CFO Ellen Snow.
- Base salary of $380,000; annual cash bonus target up to 35% of base salary.
- Granted options for 336,000 shares (4-year vest) and RSUs for 223,950 shares (3-year vest).
- Malabre previously CFO of Ultivue, Inc. and VP/Corporate Controller at Oxford Immunotec.
- Company will enter into standard Indemnification and Executive Severance Agreements.

## SEC filing metadata
- accession: 0001517022-24-000007
- form_type: 8-K
- ticker: AKBA
- cik: 0001517022
- company_name: Akebia Therapeutics, Inc.
- filed_at: 2024-01-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1517022/000151702224000007/0001517022-24-000007-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1517022/000151702224000007/akba-20240108.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001517022-24-000007
- JSON: https://secwatch.observer/filing/0001517022-24-000007.json
- Plain text: https://secwatch.observer/filing/0001517022-24-000007.txt

## Key facts
- Executive change
  Richard C. Malabre was appointed as Chief Accounting Officer at Akebia Therapeutics, Inc..
  - Action: appointed
  - Role: Chief Accounting Officer
  source text: On January 8, 2024, Akebia Therapeutics, Inc. (the “Company”) announced the appointment of Richard C. Malabre as Chief Accounting Officer and principal accounting officer, effective January 8, 2024 (the “Effective Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1517022/000151702224000007/0001517022-24-000007-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.